首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1477166

生物製藥和生物醫學市場，按產品類型、應用、治療領域、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Biopharmaceutical and Biomedicine Market, By Product Type, By Application, By Therapeutic Area, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年05月01日 | 出版商:

AnalystView Market Insights | 英文 300 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

報告要點

2023年生物製藥和生物醫學市場規模為6,213.12億美元，2024年至2032年複合年成長率為9.5%。

生物製藥和生物醫學市場-市場動態

生物製藥和生物醫學領域的產品上市和批准率激增

生物製藥和生物醫藥行業的產品上市和批准率顯著飆升，顯示該行業的快速創新和擴張。美國食品藥物管理局（FDA）的資料顯示，近年來獲得監管批准的生物製藥產品數量穩定增加，每年新藥核准數量創歷史新高。這一趨勢凸顯了該行業致力於透過開發突破性的生物製藥和生物醫學產品來解決未滿足的醫療需求並改善患者的治療結果。

生物製藥和生物醫藥市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 9.5% 左右的複合年成長率成長

根據產品類型細分，預計單株抗體將在 2023 年呈現最大市場佔有率

從應用細分來看，治療類是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

生物製藥和生物醫學市場-細分分析：

全球生物製藥和生物醫學市場根據產品類型、應用、治療領域和地區進行細分。

根據產品類型，市場分為兩類：單株抗體，廣泛用於癌症治療和自體免疫疾病等治療應用。奈米醫學用於在分子層面上診斷、治療和預防疾病，提供標靶遞送並增強藥物遞送和成像應用的功效。

根據應用市場分為三類：用於治療疾病和醫療狀況。診斷用於識別和診斷疾病或病症。研究與開發應用於藥物發現和開發的科學研究和實驗研究。

生物製藥和生物醫藥市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。

北美和歐洲是主要參與者，擁有先進的醫療基礎設施、強大的研發能力和有利的監管環境。同時，在醫療保健支出增加、慢性病盛行率增加以及創新療法普及的推動下，亞太地區展現出巨大的成長潛力。拉丁美洲以及中東和非洲地區也提供了市場擴張的機會，儘管面臨醫療基礎設施、負擔能力和監管複雜性的挑戰。

生物製藥和生物醫藥市場-競爭格局：

幾個主要參與者透過研發投資、併購和策略合作夥伴關係等策略爭奪主導地位。羅氏、輝瑞和強生等公司憑藉多樣化的生物製藥產品組合和廣泛的全球影響力引領市場。此外，安進（Amgen）、百健（Biogen）和吉利德科學（Gilead Sciences）等創新生物技術公司透過突破性療法和新型候選藥物為市場競爭力做出了貢獻。隨著競爭的加劇，企業專注於透過產品創新、法規核准和市場擴張努力來實現差異化。

市場片段
- 按產品類型分類的生物製藥和生物醫學市場片段
- 生物製藥和生物醫學市場片段（按應用）
- 按治療領域分類的生物製藥和生物醫學市場片段
- 按國家/地區分類的生物製藥和生物醫學市場摘要
- 按地區分類的生物製藥和生物醫學市場片段
競爭洞察

第 3 章：生物製藥和生物醫學主要市場趨勢

生物製藥和生物醫學市場促進因素
- 市場促進因素的影響分析
生物製藥和生物醫學市場限制
- 市場限制影響分析
生物製藥和生物醫學市場機會
生物製藥及生物醫藥市場未來趨勢

第 4 章：生物製藥和生物醫學產業研究

PEST分析
波特五力分析
成長前景圖
規範架構分析

第 5 章：生物製藥和生物醫學市場：COVID-19 影響分析

COVID-19 之前的影響分析
COVID-19 後影響分析
- 表現最佳的市場區隔
- 邊際成長市場區隔
- 最寬鬆的市場區隔
- 邊際損失市場區隔

第 6 章：生物製藥和生物醫學市場格局

2023年生物製藥和生物醫學市場佔有率分析
按主要製造商分類的故障數據
- 既有參與者分析
- 新興參與者分析

第 7 章：生物製藥和生物醫學市場 - 按產品類型

概述
- 按產品類型分類的細分市場佔有率分析
- 單株抗體
  - 疫苗
  - 重組人類胰島素
  - 人類生長激素
  - 促紅血球生成素
  - 干擾素
  - 其他
- 奈米醫學
  - 細胞與基因治療
  - 生物資訊學
  - 分子酵素和試劑盒

第 8 章：生物製藥和生物醫學市場 - 按應用

概述
- 按應用分類的細分市場佔有率分析
- 療法
- 診斷
- 研究與開發

第 9 章：生物製藥和生物醫學市場 - 按治療領域

概述
- 按治療領域分類的細分市場佔有率分析
- 腫瘤學
- 神經病學
- 心臟病學
- 免疫學
- 傳染性疾病
- 罕見疾病

第 10 章：生物製藥和生物醫學市場 - 按地理位置

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美生物製藥和生物醫學主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模和預測（按產品類型）
- 北美市場規模和預測（按應用）
- 北美市場規模與預測（按治療領域）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲生物製藥和生物醫學主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模和預測（按產品類型）
- 歐洲市場規模和預測（按應用）
- 歐洲市場規模與預測（按治療領域）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區生物製藥及生物醫學主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模與預測（依產品類型）
- 亞太地區市場規模與預測（按應用）
- 按治療領域分類的亞太市場規模和預測
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲生物製藥和生物醫學主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模與預測（按產品類型）
- 拉丁美洲市場規模與預測（按應用）
- 拉丁美洲市場規模與預測（按治療領域）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲生物製藥和生物醫學主要製造商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按產品類型）
- 中東和非洲市場規模及預測（按應用）
- 中東和非洲市場規模及預測（按治療領域）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 11 章：主要供應商分析 - 生物製藥和生物醫學產業

競爭儀表板
公司簡介
- Amgen Inc.
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- Sanofi
- Eli Lilly and Company
- AbbVie Inc.
- Novo Nordisk A/S
- Bristol-Myers Squibb Company
- NanoString
- QIAGEN
- Affimed GmbH
- GSK plc.
- Merck KgaA
- Teva Pharmaceutical Industries Ltd.
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法論
參考
縮寫
免責聲明
聯絡我們

簡介目錄圖表

Product Code: ANV2564

REPORT HIGHLIGHT

Biopharmaceutical and Biomedicine Market size was valued at USD 621,312 Million in 2023, expanding at a CAGR of 9.5% from 2024 to 2032.

The biopharmaceutical and biomedicine market encompasses the development, production, and commercialization of pharmaceuticals and medical products derived from biological sources. The growing adoption of precision medicine and personalized therapies, advancements in biotechnology such as gene editing and cell therapy, and increased focus on rare diseases and orphan drugs. However, restraints in the biopharmaceutical and biomedicine market include stringent regulatory requirements, high research and development costs, and challenges related to manufacturing and scaling up production. Opportunities abound in emerging markets, expansion into therapeutic areas with unmet medical needs, and strategic collaborations and partnerships for drug discovery and development.

Biopharmaceutical and Biomedicine Market- Market Dynamics

Surging rates of product launches and approvals in the biopharmaceuticals and biomedicines sector

The biopharmaceuticals and biomedicines sector is witnessing a notable surge in rates of product launches and approvals, indicative of the industry's rapid innovation and expansion. According to data from the U.S. Food and Drug Administration (FDA), there has been a steady increase in the number of biopharmaceutical products receiving regulatory approval in recent years, with a record number of new drug approvals reported annually. This trend underscores the industry's commitment to addressing unmet medical needs and improving patient outcomes through the development of groundbreaking biopharmaceutical and biomedicine products.

Biopharmaceutical and Biomedicine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2024-2032)

Based on product type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2023

Based on application segmentation, Therapeutics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Biopharmaceutical and Biomedicine Market- Segmentation Analysis:

The Global Biopharmaceutical and Biomedicine Market is segmented based on Product Type, Application, Therapeutic Area, and Region.

The market is divided into two categories based on product type: Monoclonal Antibodies widely used in therapeutic applications such as cancer treatment and autoimmune diseases. Nanomedicine is for diagnosing, treating, and preventing diseases at the molecular level, offering targeted delivery and enhanced efficacy in drug delivery and imaging applications.

The market is divided into three categories based on application: Utilized for treating diseases and medical conditions. Diagnostics are used for identifying and diagnosing diseases or conditions. Research and Development are applied in scientific research and experimental studies for drug discovery and development.

Biopharmaceutical and Biomedicine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America and Europe stand as key players, boasting advanced healthcare infrastructure, robust research and development capabilities, and favorable regulatory environments. Meanwhile, the Asia-Pacific region demonstrates significant growth potential, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and expanding access to innovative therapies. Latin America and the Middle East & Africa regions also present opportunities for market expansion, albeit with challenges related to healthcare infrastructure, affordability, and regulatory complexities.

Biopharmaceutical and Biomedicine Market- Competitive Landscape:

Several key players vie for dominance through strategies such as research and development investments, mergers and acquisitions, and strategic partnerships. Companies including Roche, Pfizer, and Johnson & Johnson lead the market with diverse portfolios of biopharmaceutical products and extensive global reach. Additionally, innovative biotechnology firms such as Amgen, Biogen, and Gilead Sciences contribute to market competitiveness with groundbreaking therapies and novel drug candidates. As competition intensifies, companies focus on differentiation through product innovation, regulatory approvals, and market expansion efforts.

Recent Developments:

In May 2022, JSR Life Sciences unveiled a new business division called Similis Bio, aimed at collaborating with biopharmaceutical firms to enhance efficiency and lower costs associated with biosimilar development.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Amgen Inc.

F. Hoffmann-La Roche Ltd

Johnson & Johnson Services, Inc.

Pfizer Inc.

Sanofi

Eli Lilly and Company

AbbVie Inc.

Novo Nordisk A/S

Bristol-Myers Squibb Company

NanoString

QIAGEN

Affimed GmbH

GSK plc.

Merck KgaA

Teva Pharmaceutical Industries Ltd.

Others

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Monoclonal Antibodies
Vaccines
Recombinant Human Insulin
Human Growth Hormone
Erythropoietin
Interferon
Others
Nanomedicine
Cell & Gene Therapy
Bioinformatics
Molecular Enzymes & Kits

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Therapeutics
Diagnostics
Research and Development

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

Oncology
Neurology
Cardiology
Immunology
Infectious Diseases
Rare Diseases

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Biopharmaceutical and Biomedicine Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Biopharmaceutical and Biomedicine Market Snippet by Product Type
- 2.1.2.Biopharmaceutical and Biomedicine Market Snippet by Application
- 2.1.3.Biopharmaceutical and Biomedicine Market Snippet by Therapeutic Area
- 2.1.4.Biopharmaceutical and Biomedicine Market Snippet by Country
- 2.1.5.Biopharmaceutical and Biomedicine Market Snippet by Region
2.2.Competitive Insights

3.Biopharmaceutical and Biomedicine Key Market Trends

3.1.Biopharmaceutical and Biomedicine Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Biopharmaceutical and Biomedicine Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Biopharmaceutical and Biomedicine Market Opportunities
3.4.Biopharmaceutical and Biomedicine Market Future Trends

4.Biopharmaceutical and Biomedicine Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Biopharmaceutical and Biomedicine Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Biopharmaceutical and Biomedicine Market Landscape

6.1.Biopharmaceutical and Biomedicine Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Biopharmaceutical and Biomedicine Market - By Product Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 7.1.2.Monoclonal Antibodies
  - 7.1.2.1.Vaccines
  - 7.1.2.2.Recombinant Human Insulin
  - 7.1.2.3.Human Growth Hormone
  - 7.1.2.4.Erythropoietin
  - 7.1.2.5.Interferon
  - 7.1.2.6.Others
- 7.1.3.Nanomedicine
  - 7.1.3.1.Cell & Gene Therapy
  - 7.1.3.2.Bioinformatics
  - 7.1.3.3.Molecular Enzymes & Kits

8.Biopharmaceutical and Biomedicine Market - By Application

8.1.Overview
- 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2.Therapeutics
- 8.1.3.Diagnostics
- 8.1.4.Research and Development

9.Biopharmaceutical and Biomedicine Market - By Therapeutic Area

9.1.Overview
- 9.1.1.Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
- 9.1.2.Oncology
- 9.1.3.Neurology
- 9.1.4.Cardiology
- 9.1.5.Immunology
- 9.1.6.Infectious Diseases
- 9.1.7.Rare Diseases

10.Biopharmaceutical and Biomedicine Market- By Geography

10.1.Introduction
- 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2.North America
- 10.2.1.Overview
- 10.2.2.Biopharmaceutical and Biomedicine Key Manufacturers in North America
- 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6.North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.2.7.U.S.
  - 10.2.7.1.Overview
  - 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.5.U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.2.8.Canada
  - 10.2.8.1.Overview
  - 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.5.Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.Europe
- 10.3.1.Overview
- 10.3.2.Biopharmaceutical and Biomedicine Key Manufacturers in Europe
- 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6.Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.7.Germany
  - 10.3.7.1.Overview
  - 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.5.Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.8.Italy
  - 10.3.8.1.Overview
  - 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.5.Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.9.United Kingdom
  - 10.3.9.1.Overview
  - 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.5.United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.10.France
  - 10.3.10.1.Overview
  - 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.5.France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.11.Russia
  - 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.4.Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.12.Netherlands
  - 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.4.Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.13.Sweden
  - 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.4.Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.14.Poland
  - 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.4.Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.15.Rest of Europe
  - 10.3.15.1.Overview
  - 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.5.Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.Asia Pacific (APAC)
- 10.4.1.Overview
- 10.4.2.Biopharmaceutical and Biomedicine Key Manufacturers in Asia Pacific
- 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6.Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.7.India
  - 10.4.7.1.Overview
  - 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.5.India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.8.China
  - 10.4.8.1.Overview
  - 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.5.China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.9.Japan
  - 10.4.9.1.Overview
  - 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.5.Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.10.South Korea
  - 10.4.10.1.Overview
  - 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.5.South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.11.Australia
  - 10.4.11.1.Overview
  - 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.5.Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.12.Thailand
  - 10.4.12.1.Overview
  - 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.5.Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.13.Indonesia
  - 10.4.13.1.Overview
  - 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.5.Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.14.Philippines
  - 10.4.14.1.Overview
  - 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.5.Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.15.Rest of APAC
  - 10.4.15.1.Overview
  - 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.5.Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.Latin America
- 10.5.1.Overview
- 10.5.2.Biopharmaceutical and Biomedicine Key Manufacturers in Latin America
- 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6.Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.5.7.Brazil
  - 10.5.7.1.Overview
  - 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.5.Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.5.8.Mexico
  - 10.5.8.1.Overview
  - 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.5.Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.5.9.Argentina
  - 10.5.9.1.Overview
  - 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.5.Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.5.10.Colombia
  - 10.5.10.1.Overview
  - 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.5.Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.5.11.Rest of LATAM
  - 10.5.11.1.Overview
  - 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.5.Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.Middle East and Africa
- 10.6.1.Overview
- 10.6.2.Biopharmaceutical and Biomedicine Key Manufacturers in Middle East and Africa
- 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6.Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.7.Saudi Arabia
  - 10.6.7.1.Overview
  - 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.5.Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.8.United Arab Emirates
  - 10.6.8.1.Overview
  - 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.5.United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.9.Israel
  - 10.6.9.1.Overview
  - 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.5.Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.10.Turkey
  - 10.6.10.1.Overview
  - 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.5.Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.11.Algeria
  - 10.6.11.1.Overview
  - 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.5.Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.12.Egypt
  - 10.6.12.1.Overview
  - 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.5.Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.13.Rest of MEA
  - 10.6.13.1.Overview
  - 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.5.Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Biopharmaceutical and Biomedicine Industry

11.1.Competitive Dashboard
11.2.Company Profiles
- 11.2.1.Amgen Inc.
- 11.2.2.F. Hoffmann-La Roche Ltd
- 11.2.3.Johnson & Johnson Services, Inc.
- 11.2.4.Pfizer Inc.
- 11.2.5.Sanofi
- 11.2.6.Eli Lilly and Company
- 11.2.7.AbbVie Inc.
- 11.2.8.Novo Nordisk A/S
- 11.2.9.Bristol-Myers Squibb Company
- 11.2.10.NanoString
- 11.2.11.QIAGEN
- 11.2.12.Affimed GmbH
- 11.2.13.GSK plc.
- 11.2.14.Merck KgaA
- 11.2.15.Teva Pharmaceutical Industries Ltd.
- 11.2.16.Others

12.360 Degree Analyst View

13.Appendix

13.1.Research Methodology
13.2.References
13.3.Abbreviations
13.4.Disclaimer
13.5.Contact Us

簡介目錄圖表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Biopharmaceutical and Biomedicine Market: Product Type Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Product Type
TABLE Global Biopharmaceutical and Biomedicine Market, by Product Type 2019-2032 (USD Million)
TABLE Biopharmaceutical and Biomedicine Market: Application Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Biopharmaceutical and Biomedicine Market, by Application 2019-2032 (USD Million)
TABLE Biopharmaceutical and Biomedicine Market: Therapeutic Area Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Therapeutic Area
TABLE Global Biopharmaceutical and Biomedicine Market, by Therapeutic Area 2019-2032 (USD Million)
TABLE Biopharmaceutical and Biomedicine Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Biopharmaceutical and Biomedicine Market, by Region 2019-2032 (USD Million)
TABLE North America Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
TABLE North America Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
TABLE North America Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
TABLE North America Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)
TABLE Europe Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
TABLE Europe Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
TABLE Europe Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
TABLE Europe Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)
TABLE Asia Pacific Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
TABLE Asia Pacific Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
TABLE Asia Pacific Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)
TABLE Latin America Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
TABLE Latin America Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
TABLE Latin America Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)
TABLE Middle East and Africa Biopharmaceutical and Biomedicine Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Biopharmaceutical and Biomedicine Market, by Product Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Biopharmaceutical and Biomedicine Market, by Application, 2019-2032 (USD Million)
TABLE Middle East and Africa Biopharmaceutical and Biomedicine Market, by Therapeutic Area, 2019-2032 (USD Million)